Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ5E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,512
Award facts
- Contract value 100% obligated
- $31,511.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,511.60 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Zepbound 2.5 mg/0.5 ml pen injections in 0.5 ml doses. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 21, 2026, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, allowing full and open competition among qualified vendors. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under Amerisourcebergen's parent company's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of medications and medical commodities to support military healthcare programs worldwide. Zepbound, a diabetes medication in the glucagon-like peptide-1 receptor agonist class, aligns with the contract's scope of providing specialty medications across multiple therapeutic domains to Defense Health Agency customers and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJJ5E?
SPE2DR26FJJ5E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ5E worth?
The government has obligated $31,512 on SPE2DR26FJJ5E.
Is contract SPE2DR26FJJ5E an order under another contract?
Yes. SPE2DR26FJJ5E is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ5E competed?
The extent of competition for SPE2DR26FJJ5E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award